First-trimester fetal sex determination in maternal serum using real-time PCR

An Erratum has been published for this article in Prenatal Diagnosis 22(13) 2002, 1241. Fetal sex prediction can be achieved using PCR targeted at the SRY gene by analysing cell-free fetal DNA in maternal serum. Unfortunately, the results reported to date show a lack of sensitivity, especially during the first trimester of pregnancy. Therefore, determination of fetal sex by maternal serum analysis could not replace karyotype analysis following chorionic villus sampling. A new highly sensitive real-time PCR was developped to detect an SRY gene sequence in maternal serum. Analysis was performed on 121 pregnant women during the first trimester of pregnancy (mean gestational age: 11.8 weeks). Among them, 51 had at least one previous male-bearing pregnancy. Results were compared with fetal sex. SRY PCR analysis of maternal serum was in complete concordance with fetal sex. Among the 121 pregnant women, 61 were bearing a male fetus and 60 a female fetus. No false-negative results were observed. Furthermore, no false-positive results occurred, even though 27 women carrying a female fetus during the current pregnancy had at least one previous male-bearing pregnancy. This study demonstrates that a reliable, non-invasive sex determination can be achieved by PCR analysis of maternal serum during the first trimester of pregnancy. This non-invasive approach for fetal sex prediction should have great implications in the management of pregnant women who are carriers of an X-linked genetic disorder. Prenatal diagnosis might thus be performed for male fetuses only, avoiding invasive procedures and the risk of the loss of female fetuses. Copyright © 2001 John Wiley & Sons, Ltd.     

Trophoblast-like cells sorted from peripheral maternal blood using flow cytometry: A multiparametric study involving transmission electron microscopy and fetal dna amplification

Three monoclonal antibodies (MAbs) against trophoblast (GB17, GB21, and GB25) and flow cytometry were used to sort trophoblast-like cells (TLCs) from peripheral blood of pregnant women. Sorted TLCs were processed for electron microscopy and fetal DNA amplification of the Y-specific sequences from mothers carrying male fetuses. At the ultra-structural level, most of the nucleated cells had the morphology of leucocytes, suggesting maternal contaminants, and we did not find the characteristic features of the free inter-villous trophoblast cells. Nevertheless, polymerase chain reaction (PCR) analysis showed an amplification of Y-specific sequences in two out of three samples of sorted TLCs. These results suggest that besides the maternal leucocytes, sufficient trophoblast nucleated fetal cells can be obtained using cell enrichment by sorting. This sensitive method holds promise for non-invasive prenatal diagnosis of fetal sex and if sufficient Y(positive) nuclei are found, for the diagnosis of selected numerical chromosome abnormalities.     

具有LXRα活性效应物质的新型筛查方法研究

为了检测环境中潜在的LXRα效应物质.本研究以LXRα蛋白为例,利用核受体蛋白与小分子亲和结合的原理,构建了pCold-TF-LXRα重组蛋白并优化了重组蛋白的表达条件,建立了特异性捕获活性物质的方法.结果表明：诱导温度为20℃、诱导剂IPTG浓度为0.4mmol/L为重组蛋白的最佳表达条件;同时,利用LXRα激动剂T0901317 4个梯度浓度（0.25,2.5,25,250μg/L）的加标回收率实验测得线性回归曲线为y =0.83604x+0.40763,R²=0.9948,证明方法具有有效性;对比pCold-TF空载体蛋白（6.42%）和重组蛋白（79.83%）对T0901317（250 μg/L）的回收率,说明方法具有特异性.为了验证方法的实用性,将重组蛋白与15种典型的有机磷酸酯类化合物（OPEs）的混合标样进行“捕获”实验,证明了TPHP、BPADP、TCrP、EHDPP、TNBP、RDP、TEHP、TDCIPP具有LXRα的活性效应.最后,用酵母双杂交实验验证了这8种OPEs均为LXRα的拮抗剂.     

基于铁锰泥的除砷吸附剂性能比较及吸附机理

为解决反冲洗铁锰泥粉末吸附剂（BSPA）使用后难以泥水分离问题,将除铁锰水厂生物滤池产生的反冲洗泥制成颗粒吸附剂（GA）和磁性粉末吸附剂（MPA）,并对BSPA、GA和MPA的除砷性能进行了比较,通过SEM、TED、XRD、BET、FTIR等技术对3种材料进行了表征,寻找3种吸附剂之间除砷性能差异的根源.结果表明,BSPA、GA和MPA对As （V）的最大吸附容量分别为40.980,5.048,8.694mg/g,改性后的吸附材料GA和MPA对砷的吸附能力下降.BSPA是一种以纤铁矿为主的无定形结构混合物,并混有针铁矿和结晶度差的水铁矿,GA的XRD图谱中出现石英晶体和少量赤铁矿晶体的衍射峰,而MPA的主要成分为结晶程度较高的磁赤铁矿.3种材料中均存在有利于吸附的含羟基官能团.BSPA、MPA和GA的比表面积分别为253.150,238.660,43.803m²/g.物相改变且结晶程度增加、表面羟基减少和比表面积降低是导致GA和MPA的砷吸附容量比BSPA低的主要因素.     

An investigation of methods for enriching trophoblast from maternal blood

Trophoblast deportation is known to occur in normal human pregnancy, but it is not yet clear whether these cells routinely enter the maternal peripheral circulation and are available as a source of fetal DNA for non-invasive prenatal diagnosis of genetic disorders. To resolve this issue requires an efficient method of enriching trophoblast from maternal blood combined with a means to confirm its identity. Five different techniques were tested on ten retroplacental blood samples to determine the most sensitive and operator-efficient method. Lysis of red cells alone gave the best recovery of trophoblast but had to be discounted, together with Ficoll density gradient centrifugation, due to the very low purity and the excessive time required. Fluorescence-activated cell sorting (FACS) of pre-enriched trophoblast resulted in the lowest recovery rate (8 per cent) despite a 3250-fold enrichment and a very high purity. Immunomagnetic beads (Dynabeads) coated with anti-CD 16 antibody proved to be the best method for the subsequent immunocytochemical characterization of deported trophoblast. However, IO beads coated with anti-CD45 antibody may be more useful for isolating trophoblast for prenatal diagnosis due to the high purity, enrichment (32-fold), and recovery rate (78 per cent) obtained with this method.     

The in utero diagnosis and management of alloimmune thrombocytopenia

A case is presented in which percutaneous umbilical sampling (PUBS) was utilized in the second and third trimesters for the diagnosis and management of a pregnancy at risk for neonatal alloimmune thrombocytopenia (NAIT).     

Fetal cystic hygromata: Insights gained from fetal blood sampling

Twelve second-trimester fetuses with cystic hygroma underwent fetal blood sampling for rapid karyotyping, haematologic evaluation, and blood gas analysis. An abnormal karyotype was found in seven cases: monosomy X in five, trisomy 21 in one, and trisomy 13 in the other. Eight often fetuses undergoing blood gas analysis showed hypoxaemia, five of which were growth-retarded. Nine pregnancies were terminated. Of the remaining three, only one fetus survived the perinatal period.     

耐热粉末铝合金筒体热旋成形试验

介绍了喷射沉积耐热铝合金管坯经挤压变形 ,变薄旋压筒体的研制过程 ;重点论述了热旋成形筒体的工艺路线。试验探讨了耐热铝合金的旋压温度为 35 0～ 45 0℃ ,道次变薄率约为2 0 % ,累计变薄率约 5 0 % ,需中间退火 ,退火温度宜取 35 0℃。热旋结果认为 ,喷射沉积耐热粉末铝合金铸坯直接热旋成形困难 ,需经挤压比大于 4的变形致密 ,有助于热旋成形。耐热粉末铝合金挤压坯加热变薄旋压 ,应采用小压下量多道次的变形过程 ,逐渐细化晶粒组织 ,才能旋出综合性能良好的筒形件。     

汞在鲤鱼组织中的蓄积、排出与血流速度的关系

本试验在10±1℃、不喂食条件下测定鲤鱼在30天受汞毒期间鳃、脑和肝胰脏蓄积汞和尾鳍微血管血流速度及30天解毒期间排出汞和血流速度的变化。试验结果:受毒期间鳃中汞的蓄积量最多,解毒期间鳃中汞的排出速度最快;受毒期间血流速度随受毒时间的延长而减慢,又随试验浓度的增高而减慢,解毒期间血流速度随解毒时间的延长而加快;受毒期间高浓度试验组鱼鳃、脑和肝胰脏中汞的蓄积量与血流速度呈负相关,解毒期间鱼鳃中汞的排出量与血流速度呈正相关,汞的浓度与血流速度呈负相关。     

A three-year follow-up on a child with low level trisomy 8 mosaicism which was diagnosed prenatally

We report on a case of trisomy 8 mosaicism detected prenatally in a single clone of amniotic fluid culture, and confirmed on fetal blood and on peripheral lymphocytes after birth. A follow-up was performed over 3 years, showing a clinically normal female with cognitive, neuropsychological, and linguistic development in a normal range.